Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 19, 2000, Pages 10555-10560

  Halmos, Gabor ^a,b   Schally, Andrew V ^a,b   Varga, Jozsef L ^a,b   Plonowski, Artur ^a,b,c   Rekasi, Zoltan ^a,b,d   Czompoly, Tamas ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Growth hormone releasing hormone antagonists; Tumor receptors

Indexed keywords

COMPLEMENTARY DNA; GROWTH HORMONE RELEASING FACTOR RECEPTOR; GROWTH HORMONE RELEASING HORMONE ANTAGONIST; IODINE 125; JV 1 36; JV 1 38; JV 1 42; JV 1 53; MESSENGER RNA; MZ 5 156; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; HYPOPHYSIS; KIDNEY CARCINOMA; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION;

ANIMALIA;

EID: 0034641699     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.180313097     Document Type: Article

References (40)

1. Schally, A. V. & Comaru-Schally, A. M. (2000) in Cancer Medicine, eds. Holland, J. F., Frei, E., III, Bast, R. C., Jr., Kufe, D. W., Pollock, R. E. & Weichselbaum, R. R. (Decker, Ontario), 5th Ed., pp. 715-729.
2. Schally, A. V., Kovacs, M., Toth, K. & Comaru-Schally, A. M. (1998) in Growth Hormone Secretagogues in Clinical Practice, eds. Bercu, B. B. & Walker, R. F. (Dekker, New York), pp. 145-162.
3. Schally, A. V. & Varga, J. L. (1999) Trends Endocrinol. Metab. 10, 383-391.
4. Zarandi, M., Horvath, J. E., Halmos, G., Pinski, J., Nagy, A., Groot, K., Rekasi, Z. & Schally, A. V. (1994) Proc. Natl. Acad. Sci. USA 91, 12298-12302.
5. Zarandi, M., Kovacs, M., Horvath, J. E., Toth, K., Halmos, G., Groot, K., Nagy, A., Kele, Z. & Schally, A. V. (1997) Peptides 18, 423-430.
6. Varga, J. L., Schally, A. V., Csernus, V. J., Zarandi, M., Halmos, G., Groot, K. & Rekasi, Z. (1999) Proc. Natl. Acad. Sci. USA 96, 692-697.
7. Pinski, J., Schally, A. V., Groot, K., Halmos, G., Szepeshazi, K., Zarandi, M. & Armatis, P. (1995) J. Natl. Cancer. Inst. 87, 1787-1794.
8. Pinski, J., Schally, A. V., Jungwirth, A., Groot, K., Halmos, G., Armatis, P., Zarandi, M. & Vadillo-Buenfil, M. (1996) Int. J. Oncol 9, 1099-1105.
9. Jungwirth, A., Schally, A. V., Pinski, J., Halmos, G., Groot, K., Armatis, P. & Vadillo-Buenfil, M. (1997) Br. J. Cancer 75, 1585-1592.
10. Jungwirth, A., Schally, A. V., Pinski, J., Groot, K., Armatis, P. & Halmos, G. (1997) Proc. Natl. Acad. Sci. USA 94, 5810-5813.
11. Lamharzi, N., Schally, A. V., Koppan, M. & Groot, K. (1998) Proc. Natl. Acad. Sci. USA 95, 8864-8868.
12. Kiaris, H., Schally, A. V., Varga, J. L., Groot, K. & Armatis, P. (1999) Proc. Natl. Acad. Sci. USA 96, 14894-14898.
13. Szepeshazi, K., Schally, A. V., Groot, K., Armatis, P., Hebert, F. & Halmos, G. (1999) Eur. J. Cancer 36, 128-136.
14. Kahan, Z., Varga, J. L., Schally, A. V., Rekasi, Z., Armatis, P., Chatzistamou, I., Czompoly, T. & Halmos, G. (2000) Breast Cancer Res. Treat. 60, 71-79.
15. Kiaris, H., Schally, A. V. & Varga, J. L. (2000) Neoplasia 2, 242-250.
16. Szepeshazi, K., Schally, A. V., Groot, K., Armatis, P., Halmos, G., Hebert, F., Szende, B., Varga, J. L. & Zarandi, M. (1999) Br. J. Cancer 82, 1724-1731.
17. Chatzistamou, I., Schally, A. V., Varga, J. L., Groot, K., Armatis, P. & Halmos, G. (2000) J. Clin. Endocrinol, Metab., in press.
18. Csernus, V. J., Schally, A. V., Kiaris, H. & Armatis, P. (1999) Proc. Natl. Acad. Sci. USA 96, 3098-3103.
19. Kineman, R. D. (2000) Proc. Natl. Acad. Sci. USA 97, 532-534.
20. Mayo, K. E. (1992) Mol. Endocrinol. 6, 1734-1744.
21. Gaylinn, B. D., Harrison, J. K., Zysk, J. R., Lyons, C. E., Lynch, K. R. & Thorner, M. O. (1993) Mol. Endocrinol. 7, 77-84.
22. Petersenn, S., Rasch, A. C., Heyens, M. & Schulte, H. M. (1998) Mol. Endocrinol. 12, 233-247.
23. Gaylinn, B. D. (1999) Growth Horm. IGF Res. 9, 37-44.
24. Moody, T. W., Zia, F., Draoui, M., Brenneman, D. E., Fridkin, M., Davidson, A. & Gozes, I. (1993) Proc. Natl. Acad. Sci. USA 90, 4345-4349.
25. Reubi, J. C. (1995) J. Nucl. Med. 36, 1846-1853.
26. Maruno, K., Absood, A. & Said, S.I. (1998) Proc. Natl. Acad. Sci. USA 95, 14373-14378.
27. Rekasi, Z., Varga, J. L., Schally, A. V., Halmos, G., Armatis, P., Groot, K. & Czompoly, T. (2000) Endocrinology 141, 2120-2128.
28. Tang, J., Lagace, G., Castagne, J. & Collu, R. (1995) J. Clin. Endocrinol. Metab. 80, 2381-2387.
29. Seifert, H., Perrin, M., Rivier, J. & Vale, W. (1985) Nature (London) 313, 487-489.
30. Campbell, R. M., Lee, Y., Rivier, J., Heimer, E. P., Felix, A. M. & Mowles, T. F. (1991) Peptides 12, 569-574.
31. Halmos, G., Rekasi, Z., Szoke, B. & Schally, A. V. (1993) Receptor 3, 87-97.
32. Rekasi, Z., Varga, J. L., Schally, A. V., Halmos, G., Groot, K. & Czompoly, T. (2000) Proc. Natl. Acad. Sci. USA 97, 1218-1223.
33. Gourlet, P., De Neef, P., Cnudde, J., Waelbroeck, M. & Robberecht, P. (1997) Peptides 18, 1555-1560.
34. Plonowski, A., Schally, A. V., Nagy, A., Hippokratis, H., Hebert, F. & Halmos, G. (1999) Cancer Res. 60, 2996-3001.
35. Wanke, I. E. & Rorstad, O. P. (1990) Endocrinology 126, 1981-1988.
36. Rekasi. Z., Czompoly, T., Schally, A. V. & Halmos, G. (2000) Proc. Natl. Acad. Sci. USA 97, 10561-10566.
37. Munson, P. J. & Rodbard, D. (1980) Anal. Biochem. 107, 220-239.
38. McPherson, G. A. (1985) J. Pharmacol. Methods 14, 213-228.
39. Scatchard, G. (1949) Ann. N.Y. Acad. Sci. 51, 660-675.
40. Kiaris, H. & Schally, A. V. (1999) Proc. Natl. Acad. Sci. USA 96, 226-231.